Global Estriol Market

Estriol Comprehensive Study by Type (Purity: <99%, Purity: ≥99%), Application (Pharmaceutical, Biological Research, Others), Sales Channel (Online, Offline) Players and Region - Global Market Outlook to 2030

Estriol Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Estriol
Estriol (E3) is a dominant estrogen during pregnancy and is mainly excreted by the placenta. E3 tests of placental or fetoplacental function are often used in high-risk pregnancies to predict an adverse fetal outcome. It is also used as part of hormone replacement therapy in the UK and European Union but is used less in the US and Canada due to safety concerns. Estriol is a mainstay of current strategies for determining fetal abnormalities by screening for maternal serum. It is also used as an off-label component of therapies for treating menopausal symptoms. Although estriol is a component of several bioidentical hormone replacement therapy formulations, these therapies are not approved or regulated by the FDA or Health Canada. Studies are also ongoing to test the effectiveness of this molecule as a marker for various fetal responses to pregnancy symptoms. Estriol can be important for a variety of diagnostic, screening, and therapeutic uses.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Jiangxi Yuneng Pharmaceutical (China), Shanghai Lianlu Industry (China), Jiangsu Yuanda SYM Pharmaceutical (China), Cerilliant Corporation (United States) and Arbor Assays LLC (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Estriol market by Type (Purity: <99% and Purity: ≥99%), Application (Pharmaceutical, Biological Research and Others) and Region.



On the basis of geography, the market of Estriol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. Online will boost the Estriol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Prevalence of Diseases Such As Amenorrhea, Abnormal Uterine Bleeding, Uterine Cancer Etc.

Market Growth Drivers:
Increasing Awareness About Menopausal Symptoms and Growing Population of The Post-Menopausal Women

Challenges:
Lack Of Awareness Among People

Restraints:
Strict Regulations by The Government

Opportunities:
R&D Activities by Drug Companies

In June 2023, Pfizer Inc. launched DUAVEE® (conjugated estrogens/bazedoxifene), an estrogen-based menopause hormone therapy, is now back in stock in the United States, with improved packaging, following a voluntary recall. The recall was due to an issue with the packaging and was not based on any efficacy or safety concerns with the product itself.


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Estriol, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Purity: <99%
  • Purity: ≥99%
By Application
  • Pharmaceutical
  • Biological Research
  • Others
By Sales Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness About Menopausal Symptoms
      • 3.2.2. Growing Population of The Post-Menopausal Women
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Awareness Among People
    • 3.4. Market Trends
      • 3.4.1. Increasing Prevalence of Diseases Such As Amenorrhea, Abnormal Uterine Bleeding, Uterine Cancer Etc.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Estriol, by Type, Application, Sales Channel and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Estriol (Value)
      • 5.2.1. Global Estriol by: Type (Value)
        • 5.2.1.1. Purity: <99%
        • 5.2.1.2. Purity: ≥99%
      • 5.2.2. Global Estriol by: Application (Value)
        • 5.2.2.1. Pharmaceutical
        • 5.2.2.2. Biological Research
        • 5.2.2.3. Others
      • 5.2.3. Global Estriol by: Sales Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Estriol Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Estriol (Price)
      • 5.3.1. Global Estriol by: Type (Price)
  • 6. Estriol: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Jiangxi Yuneng Pharmaceutical (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Shanghai Lianlu Industry (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Jiangsu Yuanda SYM Pharmaceutical (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cerilliant Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Arbor Assays LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Estriol Sale, by Type, Application, Sales Channel and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Estriol (Value)
      • 7.2.1. Global Estriol by: Type (Value)
        • 7.2.1.1. Purity: <99%
        • 7.2.1.2. Purity: ≥99%
      • 7.2.2. Global Estriol by: Application (Value)
        • 7.2.2.1. Pharmaceutical
        • 7.2.2.2. Biological Research
        • 7.2.2.3. Others
      • 7.2.3. Global Estriol by: Sales Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Estriol Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Estriol (Price)
      • 7.3.1. Global Estriol by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Estriol: by Type(USD Million)
  • Table 2. Estriol Purity: <99% , by Region USD Million (2018-2023)
  • Table 3. Estriol Purity: ≥99% , by Region USD Million (2018-2023)
  • Table 4. Estriol: by Application(USD Million)
  • Table 5. Estriol Pharmaceutical , by Region USD Million (2018-2023)
  • Table 6. Estriol Biological Research , by Region USD Million (2018-2023)
  • Table 7. Estriol Others , by Region USD Million (2018-2023)
  • Table 8. Estriol: by Sales Channel(USD Million)
  • Table 9. Estriol Online , by Region USD Million (2018-2023)
  • Table 10. Estriol Offline , by Region USD Million (2018-2023)
  • Table 11. South America Estriol, by Country USD Million (2018-2023)
  • Table 12. South America Estriol, by Type USD Million (2018-2023)
  • Table 13. South America Estriol, by Application USD Million (2018-2023)
  • Table 14. South America Estriol, by Sales Channel USD Million (2018-2023)
  • Table 15. Brazil Estriol, by Type USD Million (2018-2023)
  • Table 16. Brazil Estriol, by Application USD Million (2018-2023)
  • Table 17. Brazil Estriol, by Sales Channel USD Million (2018-2023)
  • Table 18. Argentina Estriol, by Type USD Million (2018-2023)
  • Table 19. Argentina Estriol, by Application USD Million (2018-2023)
  • Table 20. Argentina Estriol, by Sales Channel USD Million (2018-2023)
  • Table 21. Rest of South America Estriol, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Estriol, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Estriol, by Sales Channel USD Million (2018-2023)
  • Table 24. Asia Pacific Estriol, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Estriol, by Type USD Million (2018-2023)
  • Table 26. Asia Pacific Estriol, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Estriol, by Sales Channel USD Million (2018-2023)
  • Table 28. China Estriol, by Type USD Million (2018-2023)
  • Table 29. China Estriol, by Application USD Million (2018-2023)
  • Table 30. China Estriol, by Sales Channel USD Million (2018-2023)
  • Table 31. Japan Estriol, by Type USD Million (2018-2023)
  • Table 32. Japan Estriol, by Application USD Million (2018-2023)
  • Table 33. Japan Estriol, by Sales Channel USD Million (2018-2023)
  • Table 34. India Estriol, by Type USD Million (2018-2023)
  • Table 35. India Estriol, by Application USD Million (2018-2023)
  • Table 36. India Estriol, by Sales Channel USD Million (2018-2023)
  • Table 37. South Korea Estriol, by Type USD Million (2018-2023)
  • Table 38. South Korea Estriol, by Application USD Million (2018-2023)
  • Table 39. South Korea Estriol, by Sales Channel USD Million (2018-2023)
  • Table 40. Taiwan Estriol, by Type USD Million (2018-2023)
  • Table 41. Taiwan Estriol, by Application USD Million (2018-2023)
  • Table 42. Taiwan Estriol, by Sales Channel USD Million (2018-2023)
  • Table 43. Australia Estriol, by Type USD Million (2018-2023)
  • Table 44. Australia Estriol, by Application USD Million (2018-2023)
  • Table 45. Australia Estriol, by Sales Channel USD Million (2018-2023)
  • Table 46. Rest of Asia-Pacific Estriol, by Type USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Estriol, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Estriol, by Sales Channel USD Million (2018-2023)
  • Table 49. Europe Estriol, by Country USD Million (2018-2023)
  • Table 50. Europe Estriol, by Type USD Million (2018-2023)
  • Table 51. Europe Estriol, by Application USD Million (2018-2023)
  • Table 52. Europe Estriol, by Sales Channel USD Million (2018-2023)
  • Table 53. Germany Estriol, by Type USD Million (2018-2023)
  • Table 54. Germany Estriol, by Application USD Million (2018-2023)
  • Table 55. Germany Estriol, by Sales Channel USD Million (2018-2023)
  • Table 56. France Estriol, by Type USD Million (2018-2023)
  • Table 57. France Estriol, by Application USD Million (2018-2023)
  • Table 58. France Estriol, by Sales Channel USD Million (2018-2023)
  • Table 59. Italy Estriol, by Type USD Million (2018-2023)
  • Table 60. Italy Estriol, by Application USD Million (2018-2023)
  • Table 61. Italy Estriol, by Sales Channel USD Million (2018-2023)
  • Table 62. United Kingdom Estriol, by Type USD Million (2018-2023)
  • Table 63. United Kingdom Estriol, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Estriol, by Sales Channel USD Million (2018-2023)
  • Table 65. Netherlands Estriol, by Type USD Million (2018-2023)
  • Table 66. Netherlands Estriol, by Application USD Million (2018-2023)
  • Table 67. Netherlands Estriol, by Sales Channel USD Million (2018-2023)
  • Table 68. Rest of Europe Estriol, by Type USD Million (2018-2023)
  • Table 69. Rest of Europe Estriol, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Estriol, by Sales Channel USD Million (2018-2023)
  • Table 71. MEA Estriol, by Country USD Million (2018-2023)
  • Table 72. MEA Estriol, by Type USD Million (2018-2023)
  • Table 73. MEA Estriol, by Application USD Million (2018-2023)
  • Table 74. MEA Estriol, by Sales Channel USD Million (2018-2023)
  • Table 75. Middle East Estriol, by Type USD Million (2018-2023)
  • Table 76. Middle East Estriol, by Application USD Million (2018-2023)
  • Table 77. Middle East Estriol, by Sales Channel USD Million (2018-2023)
  • Table 78. Africa Estriol, by Type USD Million (2018-2023)
  • Table 79. Africa Estriol, by Application USD Million (2018-2023)
  • Table 80. Africa Estriol, by Sales Channel USD Million (2018-2023)
  • Table 81. North America Estriol, by Country USD Million (2018-2023)
  • Table 82. North America Estriol, by Type USD Million (2018-2023)
  • Table 83. North America Estriol, by Application USD Million (2018-2023)
  • Table 84. North America Estriol, by Sales Channel USD Million (2018-2023)
  • Table 85. United States Estriol, by Type USD Million (2018-2023)
  • Table 86. United States Estriol, by Application USD Million (2018-2023)
  • Table 87. United States Estriol, by Sales Channel USD Million (2018-2023)
  • Table 88. Canada Estriol, by Type USD Million (2018-2023)
  • Table 89. Canada Estriol, by Application USD Million (2018-2023)
  • Table 90. Canada Estriol, by Sales Channel USD Million (2018-2023)
  • Table 91. Mexico Estriol, by Type USD Million (2018-2023)
  • Table 92. Mexico Estriol, by Application USD Million (2018-2023)
  • Table 93. Mexico Estriol, by Sales Channel USD Million (2018-2023)
  • Table 94. Estriol: by Type(USD/Units)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Estriol: by Type(USD Million)
  • Table 101. Estriol Purity: <99% , by Region USD Million (2025-2030)
  • Table 102. Estriol Purity: ≥99% , by Region USD Million (2025-2030)
  • Table 103. Estriol: by Application(USD Million)
  • Table 104. Estriol Pharmaceutical , by Region USD Million (2025-2030)
  • Table 105. Estriol Biological Research , by Region USD Million (2025-2030)
  • Table 106. Estriol Others , by Region USD Million (2025-2030)
  • Table 107. Estriol: by Sales Channel(USD Million)
  • Table 108. Estriol Online , by Region USD Million (2025-2030)
  • Table 109. Estriol Offline , by Region USD Million (2025-2030)
  • Table 110. South America Estriol, by Country USD Million (2025-2030)
  • Table 111. South America Estriol, by Type USD Million (2025-2030)
  • Table 112. South America Estriol, by Application USD Million (2025-2030)
  • Table 113. South America Estriol, by Sales Channel USD Million (2025-2030)
  • Table 114. Brazil Estriol, by Type USD Million (2025-2030)
  • Table 115. Brazil Estriol, by Application USD Million (2025-2030)
  • Table 116. Brazil Estriol, by Sales Channel USD Million (2025-2030)
  • Table 117. Argentina Estriol, by Type USD Million (2025-2030)
  • Table 118. Argentina Estriol, by Application USD Million (2025-2030)
  • Table 119. Argentina Estriol, by Sales Channel USD Million (2025-2030)
  • Table 120. Rest of South America Estriol, by Type USD Million (2025-2030)
  • Table 121. Rest of South America Estriol, by Application USD Million (2025-2030)
  • Table 122. Rest of South America Estriol, by Sales Channel USD Million (2025-2030)
  • Table 123. Asia Pacific Estriol, by Country USD Million (2025-2030)
  • Table 124. Asia Pacific Estriol, by Type USD Million (2025-2030)
  • Table 125. Asia Pacific Estriol, by Application USD Million (2025-2030)
  • Table 126. Asia Pacific Estriol, by Sales Channel USD Million (2025-2030)
  • Table 127. China Estriol, by Type USD Million (2025-2030)
  • Table 128. China Estriol, by Application USD Million (2025-2030)
  • Table 129. China Estriol, by Sales Channel USD Million (2025-2030)
  • Table 130. Japan Estriol, by Type USD Million (2025-2030)
  • Table 131. Japan Estriol, by Application USD Million (2025-2030)
  • Table 132. Japan Estriol, by Sales Channel USD Million (2025-2030)
  • Table 133. India Estriol, by Type USD Million (2025-2030)
  • Table 134. India Estriol, by Application USD Million (2025-2030)
  • Table 135. India Estriol, by Sales Channel USD Million (2025-2030)
  • Table 136. South Korea Estriol, by Type USD Million (2025-2030)
  • Table 137. South Korea Estriol, by Application USD Million (2025-2030)
  • Table 138. South Korea Estriol, by Sales Channel USD Million (2025-2030)
  • Table 139. Taiwan Estriol, by Type USD Million (2025-2030)
  • Table 140. Taiwan Estriol, by Application USD Million (2025-2030)
  • Table 141. Taiwan Estriol, by Sales Channel USD Million (2025-2030)
  • Table 142. Australia Estriol, by Type USD Million (2025-2030)
  • Table 143. Australia Estriol, by Application USD Million (2025-2030)
  • Table 144. Australia Estriol, by Sales Channel USD Million (2025-2030)
  • Table 145. Rest of Asia-Pacific Estriol, by Type USD Million (2025-2030)
  • Table 146. Rest of Asia-Pacific Estriol, by Application USD Million (2025-2030)
  • Table 147. Rest of Asia-Pacific Estriol, by Sales Channel USD Million (2025-2030)
  • Table 148. Europe Estriol, by Country USD Million (2025-2030)
  • Table 149. Europe Estriol, by Type USD Million (2025-2030)
  • Table 150. Europe Estriol, by Application USD Million (2025-2030)
  • Table 151. Europe Estriol, by Sales Channel USD Million (2025-2030)
  • Table 152. Germany Estriol, by Type USD Million (2025-2030)
  • Table 153. Germany Estriol, by Application USD Million (2025-2030)
  • Table 154. Germany Estriol, by Sales Channel USD Million (2025-2030)
  • Table 155. France Estriol, by Type USD Million (2025-2030)
  • Table 156. France Estriol, by Application USD Million (2025-2030)
  • Table 157. France Estriol, by Sales Channel USD Million (2025-2030)
  • Table 158. Italy Estriol, by Type USD Million (2025-2030)
  • Table 159. Italy Estriol, by Application USD Million (2025-2030)
  • Table 160. Italy Estriol, by Sales Channel USD Million (2025-2030)
  • Table 161. United Kingdom Estriol, by Type USD Million (2025-2030)
  • Table 162. United Kingdom Estriol, by Application USD Million (2025-2030)
  • Table 163. United Kingdom Estriol, by Sales Channel USD Million (2025-2030)
  • Table 164. Netherlands Estriol, by Type USD Million (2025-2030)
  • Table 165. Netherlands Estriol, by Application USD Million (2025-2030)
  • Table 166. Netherlands Estriol, by Sales Channel USD Million (2025-2030)
  • Table 167. Rest of Europe Estriol, by Type USD Million (2025-2030)
  • Table 168. Rest of Europe Estriol, by Application USD Million (2025-2030)
  • Table 169. Rest of Europe Estriol, by Sales Channel USD Million (2025-2030)
  • Table 170. MEA Estriol, by Country USD Million (2025-2030)
  • Table 171. MEA Estriol, by Type USD Million (2025-2030)
  • Table 172. MEA Estriol, by Application USD Million (2025-2030)
  • Table 173. MEA Estriol, by Sales Channel USD Million (2025-2030)
  • Table 174. Middle East Estriol, by Type USD Million (2025-2030)
  • Table 175. Middle East Estriol, by Application USD Million (2025-2030)
  • Table 176. Middle East Estriol, by Sales Channel USD Million (2025-2030)
  • Table 177. Africa Estriol, by Type USD Million (2025-2030)
  • Table 178. Africa Estriol, by Application USD Million (2025-2030)
  • Table 179. Africa Estriol, by Sales Channel USD Million (2025-2030)
  • Table 180. North America Estriol, by Country USD Million (2025-2030)
  • Table 181. North America Estriol, by Type USD Million (2025-2030)
  • Table 182. North America Estriol, by Application USD Million (2025-2030)
  • Table 183. North America Estriol, by Sales Channel USD Million (2025-2030)
  • Table 184. United States Estriol, by Type USD Million (2025-2030)
  • Table 185. United States Estriol, by Application USD Million (2025-2030)
  • Table 186. United States Estriol, by Sales Channel USD Million (2025-2030)
  • Table 187. Canada Estriol, by Type USD Million (2025-2030)
  • Table 188. Canada Estriol, by Application USD Million (2025-2030)
  • Table 189. Canada Estriol, by Sales Channel USD Million (2025-2030)
  • Table 190. Mexico Estriol, by Type USD Million (2025-2030)
  • Table 191. Mexico Estriol, by Application USD Million (2025-2030)
  • Table 192. Mexico Estriol, by Sales Channel USD Million (2025-2030)
  • Table 193. Estriol: by Type(USD/Units)
  • Table 194. Research Programs/Design for This Report
  • Table 195. Key Data Information from Secondary Sources
  • Table 196. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Estriol: by Type USD Million (2018-2023)
  • Figure 5. Global Estriol: by Application USD Million (2018-2023)
  • Figure 6. Global Estriol: by Sales Channel USD Million (2018-2023)
  • Figure 7. South America Estriol Share (%), by Country
  • Figure 8. Asia Pacific Estriol Share (%), by Country
  • Figure 9. Europe Estriol Share (%), by Country
  • Figure 10. MEA Estriol Share (%), by Country
  • Figure 11. North America Estriol Share (%), by Country
  • Figure 12. Global Estriol: by Type USD/Units (2018-2023)
  • Figure 13. Global Estriol share by Players 2023 (%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Jiangxi Yuneng Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 16. Jiangxi Yuneng Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 17. Shanghai Lianlu Industry (China) Revenue, Net Income and Gross profit
  • Figure 18. Shanghai Lianlu Industry (China) Revenue: by Geography 2023
  • Figure 19. Jiangsu Yuanda SYM Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 20. Jiangsu Yuanda SYM Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 21. Cerilliant Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cerilliant Corporation (United States) Revenue: by Geography 2023
  • Figure 23. Arbor Assays LLC (United States) Revenue, Net Income and Gross profit
  • Figure 24. Arbor Assays LLC (United States) Revenue: by Geography 2023
  • Figure 25. Global Estriol: by Type USD Million (2025-2030)
  • Figure 26. Global Estriol: by Application USD Million (2025-2030)
  • Figure 27. Global Estriol: by Sales Channel USD Million (2025-2030)
  • Figure 28. South America Estriol Share (%), by Country
  • Figure 29. Asia Pacific Estriol Share (%), by Country
  • Figure 30. Europe Estriol Share (%), by Country
  • Figure 31. MEA Estriol Share (%), by Country
  • Figure 32. North America Estriol Share (%), by Country
  • Figure 33. Global Estriol: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Jiangxi Yuneng Pharmaceutical (China)
  • Shanghai Lianlu Industry (China)
  • Jiangsu Yuanda SYM Pharmaceutical (China)
  • Cerilliant Corporation (United States)
  • Arbor Assays LLC (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 229 Pages 50 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Estriol Market Quantitative research analysis
Global Estriol Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Jiangxi Yuneng Pharmaceutical (China), Shanghai Lianlu Industry (China), Jiangsu Yuanda SYM Pharmaceutical (China), Cerilliant Corporation (United States) and Arbor Assays LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Prevalence of Diseases Such As Amenorrhea, Abnormal Uterine Bleeding, Uterine Cancer Etc." is seen as one of major influencing trends for Estriol Market during projected period 2023-2030.
The Estriol market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Estriol Market Report?

Have a Query? Click Here

Other Related Reports

MS Polymer Adhesives Comprehensive Study by Type (Adhesive, Sealants, Primer), Application (Automotive & Transportation, Building & Construction, Industrial Assembly, Others), Sales Channel (Online, ...
$ 3500
Skin Bioactive Comprehensive Study by Application (All Skin Types, Dry Skin, Combination Skin, Oily Skin), Form (Liquid, Paste/Gel), Distribution Channel (Online, Offline), Packaging Size (Under 15ml...
$ 3450
Copper Edta Comprehensive Study by Type (Bio-Tech Grade, Industrial Grade, Chemical Grade), Form (Powder, Liquid), Distribution Channel (Direct, Indirect), Packaging Type (PP Bag with LDPE, Jumbo Bag...
$ 3500
Benzyl Acetoacetate Comprehensive Study by Type (Food Grade, Industrial Grade), Application (Food & Beverages, Pharmaceuticals, Chemicals, Others), Distribution Channel (Direct, Indirect), Concentrat...
$ 3350
Acetoacetic Acid Comprehensive Study by Type (Above 98%, Below 98%), Application (Chemical Industries, Pharmaceutical industries, Paper & pulp, Textile, Others), Constituents (Enzyme, Protein, Glucos...
$ 3650
Ziegler Natta Catalyst Comprehensive Study by Type (Metallocene catalysts, Non-Metallocene catalysts, Others), Application (Polyethylene, Polypropylene, Polymethylpentene, Polycycloolefins, Polybutad...
$ 3650